HUP9904201A3 - Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent - Google Patents
Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agentInfo
- Publication number
- HUP9904201A3 HUP9904201A3 HU9904201A HUP9904201A HUP9904201A3 HU P9904201 A3 HUP9904201 A3 HU P9904201A3 HU 9904201 A HU9904201 A HU 9904201A HU P9904201 A HUP9904201 A HU P9904201A HU P9904201 A3 HUP9904201 A3 HU P9904201A3
- Authority
- HU
- Hungary
- Prior art keywords
- transfecting
- viral
- nucleic acid
- gene therapy
- recombinant virus
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 238000001415 gene therapy Methods 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 239000013612 plasmid Substances 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/10—Vectors comprising a non-peptidic targeting moiety
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9614693A FR2756491B1 (fr) | 1996-11-29 | 1996-11-29 | Composition transfectante utile en therapie genique associan t a un virus recombinant incorporant un acide nucleique exog ene, un agent de transfection non viral et non plasmidique |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9904201A1 HUP9904201A1 (hu) | 2000-04-28 |
HUP9904201A3 true HUP9904201A3 (en) | 2002-01-28 |
Family
ID=9498192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9904201A HUP9904201A3 (en) | 1996-11-29 | 1997-11-28 | Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0948636A1 (hu) |
JP (1) | JP2001514485A (hu) |
KR (1) | KR20000057307A (hu) |
AU (1) | AU737846B2 (hu) |
BR (1) | BR9713434A (hu) |
CA (1) | CA2272637A1 (hu) |
CZ (1) | CZ188299A3 (hu) |
FR (1) | FR2756491B1 (hu) |
HU (1) | HUP9904201A3 (hu) |
IL (1) | IL130053A0 (hu) |
NO (1) | NO992577L (hu) |
SK (1) | SK70999A3 (hu) |
WO (1) | WO1998023765A1 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100764890B1 (ko) * | 2005-11-14 | 2007-10-09 | 한국화학연구원 | 폴리에틸렌이민과 인지질을 접합하여 제조된 리포솜을이용한 항암주사제 및 이의 제조방법 |
WO2008097623A2 (en) | 2007-02-07 | 2008-08-14 | Gradalis, Inc. | Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy |
KR100980395B1 (ko) | 2008-06-27 | 2010-09-07 | 재단법인서울대학교산학협력재단 | 비-바이러스성 유전자 전달체용 중합체/유전자 복합체 |
JP5944622B2 (ja) * | 2011-04-08 | 2016-07-05 | 株式会社ブリヂストン | 遺伝子導入剤組成物 |
US9598713B2 (en) | 2012-03-02 | 2017-03-21 | Japanese Science And Technology Agency | Method for constructing functional nucleic acid molecule, and nucleic acid combination to be used in said method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2646161B1 (fr) * | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
US5552309A (en) * | 1994-09-30 | 1996-09-03 | Indiana University Foundation | Use of polyols for improving the introduction of genetic material into cells |
FR2727679B1 (fr) * | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
FR2730637B1 (fr) * | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
FR2741066B1 (fr) * | 1995-11-14 | 1997-12-12 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
-
1996
- 1996-11-29 FR FR9614693A patent/FR2756491B1/fr not_active Expired - Fee Related
-
1997
- 1997-11-28 IL IL13005397A patent/IL130053A0/xx unknown
- 1997-11-28 WO PCT/FR1997/002157 patent/WO1998023765A1/fr not_active Application Discontinuation
- 1997-11-28 CA CA002272637A patent/CA2272637A1/fr not_active Abandoned
- 1997-11-28 JP JP52437898A patent/JP2001514485A/ja active Pending
- 1997-11-28 HU HU9904201A patent/HUP9904201A3/hu unknown
- 1997-11-28 AU AU74010/98A patent/AU737846B2/en not_active Ceased
- 1997-11-28 CZ CZ991882A patent/CZ188299A3/cs unknown
- 1997-11-28 KR KR1019990704738A patent/KR20000057307A/ko not_active Application Discontinuation
- 1997-11-28 EP EP97948959A patent/EP0948636A1/fr not_active Withdrawn
- 1997-11-28 SK SK709-99A patent/SK70999A3/sk unknown
- 1997-11-28 BR BR9713434-1A patent/BR9713434A/pt not_active IP Right Cessation
-
1999
- 1999-05-28 NO NO992577A patent/NO992577L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SK70999A3 (en) | 2000-03-13 |
BR9713434A (pt) | 2000-02-01 |
IL130053A0 (en) | 2000-02-29 |
NO992577D0 (no) | 1999-05-28 |
KR20000057307A (ko) | 2000-09-15 |
CA2272637A1 (fr) | 1998-06-04 |
AU7401098A (en) | 1998-06-22 |
AU737846B2 (en) | 2001-08-30 |
HUP9904201A1 (hu) | 2000-04-28 |
EP0948636A1 (fr) | 1999-10-13 |
WO1998023765A1 (fr) | 1998-06-04 |
CZ188299A3 (cs) | 1999-09-15 |
JP2001514485A (ja) | 2001-09-11 |
FR2756491A1 (fr) | 1998-06-05 |
NO992577L (no) | 1999-07-28 |
FR2756491B1 (fr) | 1999-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000054813A3 (en) | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye | |
BR9405507A (pt) | Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica | |
ZA958686B (en) | Viral vectors and use in gene therapy | |
ZA949104B (en) | Recombinant viruses and their use in gene therapy | |
AU9692198A (en) | Gene delivery compositions and methods | |
ZA952563B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL181695A0 (en) | Methods for cultivating cells and propagating viruses | |
GB9721909D0 (en) | Gene delivery vectors and their uses | |
AU1927797A (en) | Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines | |
ZA949103B (en) | Recombinant viruses and their use in gene therapy | |
HUP9904201A3 (en) | Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent | |
IL117116A0 (en) | A medical composition for the in vivo transfection and expression of exogenes | |
AU5008296A (en) | Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy | |
AU9269898A (en) | Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy | |
MX9702078A (es) | Adenovirus que comprenden dos genes terapeuticos: suicida e inmunoestimulante. | |
IL112993A0 (en) | Recombinant niruses, their preparation and their use in gene therapy | |
IL112992A0 (en) | Recombinant viruses, their preparation and their use in gene therapy | |
AU2176997A (en) | Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use | |
PL346859A1 (en) | Recombinant celo virus and celo virus dna | |
ZA971070B (en) | Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent. | |
IL112994A0 (en) | Recombinant viruses, their preparation and their use in gene therapy | |
ZA952286B (en) | Recombinant viruses their preparation and their use in gene therapy | |
AU2003200630A1 (en) | Mammalian genes involved in viral infection and tumor suppression | |
AU3698699A (en) | Vectors and viruses used in gene therapy | |
AU5217100A (en) | Adenoviral vectors encoding interferon and their use in gene therapy |